(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC): successful treatment of a patient with disseminated esophageal and hypopharyngeal papillomatosis

Robert Snoeck; Eric Van Cutsem; Marc Van Ranst; Paul Rutgeerts; Ghislain Opdenakker; De Clercq Erik

Back

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC): successful treatment of a patient with disseminated esophageal and hypopharyngeal papillomatosis

Article 1994 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1994

HPMPC treatment of a patient with esophageal and hypopharyngeal papillomatosis

Marc Van Ranst, Robert Snoeck, Eric Van Cutsem, Paul Rutgeerts, Ghislain Opdenakker, De Clercq Erik

Article1997

Treatment of severe laryngeal papillomatosis with intralesional injections of Cidofovir R [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC, Vistide R],

W Wellens, Robert Snoeck, C De Sloovere, Marc Van Ranst, Lieve Naesens, De Clercq Erik, Louw Feenstra

Article1998

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]

Robert Snoeck, W Wellens, Christian Desloovere, Marc Van Ranst, Lieve Naesens, De Clercq Erik, Louw Feenstra

Article1994

Successful Treatment of Progressive Mucocutaneous Infection Due to Acyclovirand Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine (HPMPC)

Robert Snoeck, Graciela Andreï, M. Gérard, Alan Silverman, Ann Hedderman, Jan Balzarini, Catherine Sadzot‐Delvaux, G Tricot, Nathan Clumeck, De Clercq Erik

Article1995

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC): successful treatment of a patient with disseminated esophageal and hypopharyngeal papillomatosis

Discussion(0)

Related publications

HPMPC treatment of a patient with esophageal and hypopharyngeal papillomatosis

Treatment of severe laryngeal papillomatosis with intralesional injections of Cidofovir R [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC, Vistide R],

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]

Successful Treatment of Progressive Mucocutaneous Infection Due to Acyclovirand Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine (HPMPC)

Successful treatment of severe anogenital papillomavirus infections in AIDS patients with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine